— Know what they know.
Not Investment Advice
Also trades as: 4536.T (JPX) · $vol 13M · SNPHY (OTC) · $vol 0M

SNPHF OTC

Santen Pharmaceutical Co., Ltd.
1W: +1.0% 1M: +0.0% 3M: +0.0% YTD: +37.2% 1Y: +14.0% 3Y: +44.7% 5Y: -3.3%
$13.05
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - General · Tech Score Neutral · Power 62 · $4.2B mcap · 290M float · 0.0000% daily turnover · Short 100% of daily vol

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
Oct 02, 2026
DCF
4
ROE
4
ROA
5
D/E
2
P/E
3
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. SNPHF receives an overall rating of A-. Strongest factors: DCF (4/5), ROE (4/5), ROA (5/5). Areas of concern: D/E (2/5).
Rating Change History
DateFromTo
2026-07-28 A A-
2026-07-11 A- A
2026-07-01 None ADDED
2026-06-30 EXISTED None
2026-06-25 None ADDED
2026-03-18 EXISTED None
2026-03-13 None ADDED

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A
Profitability
66
Balance Sheet
94
Earnings Quality
66
Growth
40
Value
—
Momentum
62
Safety
—
Cash Flow
48

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
7/9
✓ ✓ ✓ ✗ ✓ ✓ ✓ ✓ ✗
Beneish M-Score
-2.47
Unlikely Manipulator
Ohlson O-Score
-11.59
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 82.8/100
Trend: Stable
Earnings Quality
75/100
OCF/NI: 0.96x
Accruals: 0.4%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SNPHF scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. SNPHF's score of -2.47 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SNPHF's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SNPHF receives an estimated rating of AA- (score: 82.8/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). SNPHF's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
13.82x
PEG
0.46x
P/S
1.81x
P/B
1.76x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$1543.34
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 13.8x earnings, SNPHF trades at a reasonable valuation. Graham's intrinsic value formula yields $1543.34 per share, suggesting a potential 11726% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.788
NI / EBT
×
Interest Burden
1.031
EBT / EBIT
×
EBIT Margin
0.158
EBIT / Rev
×
Asset Turnover
0.702
Rev / Assets
×
Equity Multiplier
1.427
Assets / Equity
=
ROE
12.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SNPHF's ROE of 12.8% is driven by Asset Turnover (0.702), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
8.63%
Fair P/E
25.76x
Intrinsic Value
$2972.14
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with SNPHF's realized 8.6% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. SNPHF trades at a premium to its adjusted intrinsic value of $2972.14, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 25.8x compares to the current market P/E of 13.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$13.05
Median 1Y
$12.37
5th Pctile
$7.66
95th Pctile
$19.97
Ann. Volatility
28.7%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
ROE 2.6% 2.3% 1.6% 8.4% 8.1% -2.9% -2.6% -4.7% -3.5% 8.5% 9.2% 8.9% 8.8% 8.8% 9.4% 12.2% 10.7% 21.7% 10.8% 12.8% 12.85%
ROA 2.0% 1.7% 1.2% 6.3% 6.2% -2.1% -1.9% -3.4% -2.6% 6.2% 6.5% 6.2% 6.3% 6.3% 6.7% 8.6% 7.5% 15.3% 7.7% 9.0% 9.00%
ROIC 3.1% 2.9% 2.0% 9.6% 8.8% -0.6% -0.2% -0.9% 0.4% 10.5% 12.1% 14.0% 15.9% 16.8% 16.6% 15.6% 15.7% -46.6% 11.2% 14.4% 14.40%
ROCE 4.3% 3.8% 3.5% 10.1% 9.9% -0.2% 0.1% -1.0% 0.1% 11.5% 12.6% 15.1% 15.1% 15.7% 16.0% 15.3% 13.6% 20.5% 13.3% 13.7% 13.72%
Gross Margin 58.6% 59.3% 55.5% 61.7% 56.7% 56.6% 58.3% 65.3% 58.5% 59.9% 58.3% 57.0% 57.2% 56.0% 55.3% 59.7% 54.0% 54.7% 52.9% 61.4% 61.43%
Operating Margin 14.7% 15.1% 11.3% 13.5% 12.7% -43.2% 12.5% 8.9% 17.6% 16.8% 14.4% 3.0% 17.6% 16.9% 15.4% 12.8% 11.0% 14.9% 14.1% 21.1% 21.11%
Net Margin 11.3% 10.9% 7.5% 11.2% 10.2% -45.3% 8.4% 1.4% 14.4% 12.1% 9.5% 0.0% 14.2% 11.4% 11.4% 11.4% 8.6% 11.7% 10.8% 19.2% 19.22%
EBITDA Margin 20.0% 22.2% 17.6% 21.2% 20.9% -36.6% 18.3% 13.5% 23.6% 22.6% 20.4% 26.0% 23.9% 21.0% 20.7% 23.9% 17.6% 22.1% 21.1% 26.7% 26.75%
FCF Margin 5.3% 8.6% 8.6% 3.8% 3.2% 0.0% 2.7% 4.5% 5.6% 11.0% 19.0% 20.5% 24.3% 21.5% 15.1% 18.1% 14.5% 11.3% 10.3% 10.6% 10.58%
OCF Margin 13.2% 18.3% 17.5% 17.3% 17.2% 14.0% 16.0% 13.3% 13.0% 15.7% 22.5% 24.1% 27.0% 24.2% 18.3% 20.3% 16.6% 13.2% 11.7% 12.3% 12.30%
ROE 3Y Avg snapshot only 11.32%
ROE 5Y Avg snapshot only 7.39%
ROA 3Y Avg snapshot only 7.93%
ROIC 3Y Avg snapshot only 11.86%
ROIC Economic snapshot only 11.00%
Cash ROA snapshot only 8.47%
Cash ROIC snapshot only 14.41%
CROIC snapshot only 12.40%
NOPAT Margin snapshot only 12.29%
Pretax Margin snapshot only 16.28%
R&D / Revenue snapshot only 8.98%
SGA / Revenue snapshot only 30.71%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — 13.817
P/S Ratio — — — — — — — — — — — — — — — — — — — — 1.814
P/B Ratio — — — — — — — — — — — — — — — — — — — — 1.761
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
PEG Ratio snapshot only 0.462
Graham Number snapshot only $1543.34
Leverage & Solvency
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Current Ratio 2.89 2.81 2.58 2.39 2.48 2.91 2.73 2.38 2.67 2.66 2.46 2.54 2.60 2.61 2.61 2.58 2.56 2.65 2.68 2.60 2.603
Quick Ratio 2.29 2.27 2.10 2.01 2.03 2.36 2.23 1.94 2.11 2.10 1.94 2.08 2.03 1.97 1.98 1.99 1.88 -116.54 1.89 1.87 1.868
Debt/Equity 0.03 0.06 0.07 0.10 0.06 0.12 0.12 0.12 0.12 0.11 0.11 0.11 0.00 0.00 0.00 0.12 0.00 0.13 0.13 0.12 0.116
Net Debt/Equity -0.14 -0.18 -0.15 -0.15 -0.14 -0.10 -0.08 -0.08 -0.04 -0.11 -0.16 -0.20 -0.29 -0.30 -0.27 -0.21 -0.30 -35.45 -0.09 -0.16 -0.163
Debt/Assets 0.03 0.05 0.05 0.07 0.05 0.09 0.09 0.09 0.08 0.08 0.08 0.08 0.00 0.00 0.00 0.08 0.00 0.09 0.09 0.08 0.082
Debt/EBITDA 0.32 0.66 0.73 0.61 0.41 2.22 2.02 2.56 1.98 0.59 0.56 0.50 0.00 0.00 0.00 0.51 0.00 0.00 0.59 0.54 0.537
Net Debt/EBITDA -1.46 -1.86 -1.62 -0.95 -0.87 -1.85 -1.37 -1.59 -0.71 -0.57 -0.81 -0.85 -1.27 -1.24 -1.12 -0.89 -1.37 -1.06 -0.41 -0.75 -0.751
Interest Coverage 8.97 12.55 11.34 30.46 34.95 -0.45 0.23 -1.37 0.20 15.55 19.74 17.04 15.84 16.32 21.17 66.03 94.72 79.19 49.60 33.62 33.617
Equity Multiplier 1.27 1.32 1.34 1.36 1.34 1.38 1.40 1.43 1.38 1.39 1.43 1.42 1.42 1.42 1.40 1.43 1.45 1.42 1.42 1.42 1.424
Cash Ratio snapshot only 0.943
Debt Service Coverage snapshot only 47.027
Cash to Debt snapshot only 2.398
FCF to Debt snapshot only 0.893
Defensive Interval snapshot only 479.3 days
Efficiency & Turnover
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Asset Turnover 0.64 0.62 0.63 0.62 0.62 0.63 0.64 0.63 0.65 0.69 0.71 0.70 0.72 0.72 0.73 0.71 0.70 1.42 0.72 0.70 0.702
Inventory Turnover 2.53 2.52 2.72 2.79 2.77 2.84 2.94 2.95 2.80 2.75 2.83 3.04 2.74 2.63 2.72 2.72 2.33 2.29 2.34 2.22 2.216
Receivables Turnover 2.92 3.10 2.93 2.72 2.75 3.06 2.88 2.70 2.81 3.27 3.37 3.05 3.25 3.68 3.92 3.70 3.89 8.18 4.20 4.07 4.073
Payables Turnover 2.97 2.88 3.07 2.77 3.01 3.01 2.81 2.62 2.81 2.87 2.75 2.84 2.94 3.03 3.26 3.12 2.92 6.16 3.75 3.46 3.464
DSO 125 118 124 134 133 119 127 135 130 112 108 119 112 99 93 99 94 45 87 90 89.6 days
DIO 144 145 134 131 132 129 124 124 130 133 129 120 133 139 134 134 157 159 156 165 164.7 days
DPO 123 127 119 132 121 121 130 139 130 127 133 129 124 120 112 117 125 59 97 105 105.4 days
Cash Conversion Cycle 147 136 140 133 143 126 121 120 130 117 104 111 121 118 115 116 125 145 146 149 149.0 days
Fixed Asset Turnover snapshot only 3.730
Operating Cycle snapshot only 254.3 days
Cash Velocity snapshot only 3.518
Capital Intensity snapshot only 1.452
Growth (YoY)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 7.1% 7.4% 9.4% 6.7% 3.8% 2.7% 2.5% 4.8% 7.2% 11.1% 11.8% 8.2% 6.5% 2.2% -0.1% -0.6% -3.4% -3.3% -4.3% -2.3% -2.27%
Net Income -66.1% -70.0% -78.6% 3.0% 2.3% -2.2% -2.6% -1.5% -1.4% 3.9% 4.4% 2.8% 3.4% -0.9% -0.8% 36.1% 17.3% 20.7% 11.8% 3.7% 3.65%
EPS -66.1% -70.0% -78.6% 3.0% 2.4% -2.3% -2.6% -1.6% -1.4% 4.0% 4.7% 2.8% 3.5% 2.0% 2.1% 44.8% 24.3% 24.7% 19.0% 8.6% 8.63%
FCF -49.1% 30.9% 72.4% -32.0% -37.5% -99.9% -67.7% 23.1% 86.6% 1921.8% 6.8% 3.9% 3.6% 99.0% -20.4% -12.4% -42.2% -49.2% -34.8% -42.8% -42.83%
EBITDA -36.8% -39.1% -40.4% 78.8% 76.2% -43.4% -36.8% -73.8% -67.9% 2.3% 2.3% 4.0% 3.0% 20.7% 15.4% -3.9% -13.2% -10.6% -11.4% -3.7% -3.72%
Op. Income -55.3% -59.6% -61.0% 1.8% 1.4% -1.1% -1.1% -1.1% -96.2% 22.1% 68.4% 13.5% 28.3% -5.7% -8.8% 21.6% 6.0% 2.7% -3.0% -2.9% -2.90%
OCF Growth snapshot only -40.82%
Asset Growth snapshot only 4.01%
Equity Growth snapshot only 4.41%
Debt Growth snapshot only 1.53%
Shares Change snapshot only -4.58%
Dividend Growth snapshot only 9.46%
Growth (CAGR)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 3Y 4.5% 4.3% 4.7% 4.4% 4.1% 3.8% 3.6% 4.9% 6.0% 7.0% 7.8% 6.6% 5.8% 5.3% 4.6% 4.1% 3.3% 3.2% 2.3% 1.7% 1.66%
Revenue 5Y 5.4% 5.9% 6.0% 6.0% 5.4% 4.7% 4.5% 4.4% 4.9% 5.3% 5.6% 5.2% 5.2% 4.9% 4.4% 4.4% 4.1% 3.9% 3.7% 3.3% 3.27%
EPS 3Y -37.5% -40.0% -44.7% -4.7% -5.3% — — — — 6.4% 8.9% 62.9% 55.5% 59.9% 83.2% 16.0% 11.5% — — — —
EPS 5Y -31.1% -19.4% -25.6% 3.8% 2.0% — — — — -2.8% 0.4% -1.3% -1.1% -0.6% 2.0% 12.4% 9.6% 8.9% 9.4% 46.7% 46.73%
Net Income 3Y -37.9% -40.4% -45.0% -5.2% -5.5% — — — — 2.8% 4.6% 57.8% 50.2% 53.1% 74.3% 10.0% 5.9% — — — —
Net Income 5Y -31.6% -20.0% -25.9% 3.5% 1.5% — — — — -5.2% -2.4% -3.6% -3.1% -3.2% -1.0% 8.9% 6.1% 5.4% 4.9% 40.9% 40.86%
EBITDA 3Y -13.7% -15.4% -18.7% -1.8% -1.5% -33.1% -30.9% -34.5% -29.0% 4.8% 7.1% 32.4% 31.7% 31.6% 33.6% 7.7% 4.0% 53.3% 49.5% 66.1% 66.06%
EBITDA 5Y -7.6% — — 4.7% 4.3% -17.7% -16.8% -22.2% -18.3% 2.7% 2.1% 4.2% 4.4% 3.8% 4.5% 6.0% 4.6% 4.4% 4.7% 16.5% 16.53%
Gross Profit 3Y 4.4% 4.3% 4.4% 3.0% 2.4% 1.9% 2.2% 4.2% 5.8% 7.2% 8.2% 5.2% 4.1% 3.0% 2.4% 3.0% 2.1% 2.1% 0.5% -0.4% -0.41%
Gross Profit 5Y 4.8% 5.3% 5.2% 4.8% 4.2% 3.3% 3.4% 3.7% 4.5% 5.2% 5.6% 4.2% 4.1% 3.6% 2.9% 3.1% 2.8% 2.4% 2.1% 1.6% 1.62%
Op. Income 3Y -26.7% -29.6% -33.5% -7.0% -7.5% — — — -65.5% 7.3% 10.7% 44.0% 39.2% 42.3% 47.0% 8.9% 5.6% — — — —
Op. Income 5Y -29.0% -16.8% -17.9% 2.2% 0.8% — — — -48.5% 1.3% 0.4% -3.1% -2.6% -2.2% -0.5% 6.9% 5.0% 3.6% 3.7% 28.7% 28.65%
FCF 3Y -17.3% -8.3% -4.9% -25.4% -35.7% -91.7% -36.7% -25.8% -15.9% 24.5% 63.1% 60.4% 75.3% 43.1% 26.1% 74.6% 70.8% 11.5% 59.4% 35.2% 35.18%
FCF 5Y — — — 50.0% -18.3% -77.4% -24.7% -17.5% -8.0% 2.6% 16.7% 20.3% 18.1% 16.7% 9.6% 12.1% 9.7% 14.3% 17.6% 15.6% 15.64%
OCF 3Y -0.6% 7.4% 8.2% 11.9% 3.8% -1.7% 4.9% -2.4% -4.2% 10.2% 23.2% 23.2% 34.4% 15.5% 6.2% 9.8% 2.1% 1.2% -7.9% -1.0% -0.99%
OCF 5Y 31.6% 56.3% 56.8% 33.5% 8.8% -0.2% 1.8% -2.8% 1.5% 3.9% 13.3% 17.2% 14.9% 13.3% 8.0% 8.8% 2.9% 2.1% -1.5% -1.5% -1.46%
Assets 3Y 1.6% 1.7% 3.4% 5.5% 6.1% 2.4% 1.0% 1.0% 0.6% 0.5% 1.2% 2.7% 3.0% -0.9% -2.5% -3.8% -4.0% -81.7% -1.5% 0.4% 0.36%
Assets 5Y 3.8% 5.4% 6.0% 7.3% 7.2% 2.7% 2.1% 1.6% 1.9% 1.3% 2.0% 2.2% 2.4% 0.6% -0.5% 0.0% -0.1% -63.7% -0.6% 1.1% 1.13%
Equity 3Y 2.7% 1.8% 2.7% 5.1% 6.0% 1.8% -0.1% -1.0% -0.6% -0.9% -1.8% -0.2% -0.5% -3.3% -4.0% -5.3% -6.5% -81.8% -2.0% 0.6% 0.55%
Book Value 3Y 3.4% 2.5% 3.3% 5.6% 6.3% 3.6% 1.0% 0.9% 1.7% 2.5% 2.3% 3.0% 3.0% 1.0% 0.9% -0.2% -1.5% -81.2% 4.0% 5.6% 5.57%
Dividend 3Y 1.8% 1.9% 2.9% 2.9% 4.9% 6.4% 2.9% 3.6% 0.7% 1.9% 2.1% 1.2% 3.1% 4.0% 5.8% 6.1% 6.4% 4.8% 7.6% 6.5% 6.53%
Growth Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue Stability 0.97 0.96 0.94 0.97 0.98 0.98 0.94 0.97 0.97 0.92 0.91 0.96 0.97 0.95 0.92 0.95 0.88 0.81 0.71 0.74 0.743
Earnings Stability 0.70 0.22 0.37 0.15 0.19 0.71 0.82 0.62 0.62 0.32 0.24 0.13 0.13 0.01 0.00 0.05 0.04 0.20 0.21 0.34 0.343
Margin Stability 0.98 0.99 0.98 0.98 0.98 0.97 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.97 0.97 0.98 0.97 0.97 0.96 0.97 0.968
Rev. Growth Consistency 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.92 0.95 0.99 0.985
Earnings Smoothness 0.01 0.00 0.00 0.00 0.00 — — — — — — — — 0.99 0.99 0.69 0.84 0.81 0.89 0.96 0.964
ROE Trend -0.07 -0.07 -0.07 0.03 0.03 -0.08 -0.07 -0.10 -0.09 0.09 0.10 0.07 0.07 0.06 0.06 0.11 0.09 16.89 0.01 0.02 0.019
Gross Margin Trend 0.00 0.00 -0.00 -0.02 -0.02 -0.03 -0.02 -0.00 0.00 0.01 0.01 -0.01 -0.01 -0.02 -0.03 -0.02 -0.03 -0.03 -0.03 -0.02 -0.018
FCF Margin Trend -0.07 -0.01 -0.00 -0.06 -0.05 -0.08 -0.04 -0.00 0.01 0.07 0.13 0.16 0.20 0.16 0.04 0.06 -0.00 -0.05 -0.07 -0.09 -0.087
Sustainable Growth Rate -1.1% -1.2% -2.1% 4.7% 4.2% — — — — 4.6% 5.3% 4.9% 4.9% 4.7% 5.3% 8.2% 6.5% 13.1% 6.4% 8.5% 8.52%
Internal Growth Rate — — — 3.7% 3.3% — — — — 3.4% 3.9% 3.6% 3.6% 3.5% 3.9% 6.1% 4.7% 10.2% 4.7% 6.4% 6.35%
Cash Flow Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
OCF/Net Income 4.28 6.52 8.89 1.69 1.73 -4.10 -5.32 -2.48 -3.33 1.76 2.46 2.73 3.06 2.80 2.01 1.68 1.55 1.22 1.10 0.96 0.959
FCF/OCF 0.40 0.47 0.49 0.22 0.19 0.00 0.17 0.34 0.43 0.70 0.84 0.85 0.90 0.89 0.83 0.89 0.88 0.86 0.88 0.86 0.860
FCF/Net Income snapshot only 0.825
OCF/EBITDA snapshot only 0.557
CapEx/Revenue 7.9% 9.7% 8.9% 13.5% 14.0% 14.0% 13.3% 8.8% 7.4% 4.7% 3.6% 3.5% 2.7% 2.7% 3.2% 2.2% 2.1% 1.9% 1.4% 1.7% 1.72%
CapEx/Depreciation snapshot only 0.273
Accruals Ratio -0.06 -0.10 -0.10 -0.04 -0.05 -0.11 -0.12 -0.12 -0.11 -0.05 -0.10 -0.11 -0.13 -0.11 -0.07 -0.06 -0.04 -0.03 -0.01 0.00 0.004
Sloan Accruals snapshot only -0.034
Cash Flow Adequacy snapshot only 2.039
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 2.43%
Dividend/Share $27.93 $27.95 $29.90 $29.95 $32.22 $33.70 $32.57 $33.44 $32.64 $33.77 $33.51 $32.71 $33.45 $34.26 $35.19 $35.48 $36.52 $36.52 $39.08 $38.83 $40.00
Payout Ratio 1.4% 1.5% 2.3% 44.0% 48.2% — — — — 46.3% 42.9% 44.6% 44.9% 46.1% 44.1% 33.4% 39.4% 39.4% 41.2% 33.7% 33.66%
FCF Payout Ratio 81.5% 50.4% 52.6% 1.2% 1.5% 752.9% 1.7% 1.0% 76.3% 37.4% 20.7% 19.2% 16.3% 18.5% 26.6% 22.3% 29.1% 37.6% 42.5% 40.8% 40.77%
Total Payout Ratio 1.4% 1.5% 2.3% 44.1% 75.4% — — — — 1.4% 1.3% 1.1% 1.3% 1.6% 1.8% 1.4% 1.5% 1.7% 1.5% 1.2% 1.22%
Div. Increase Streak 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 1 0
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Tax Burden (NI/EBT) 0.58 0.57 0.45 0.76 0.75 4.84 4.94 2.58 5.59 0.71 0.70 0.89 0.88 0.88 0.87 0.76 0.76 0.76 0.76 0.79 0.788
Interest Burden (EBT/EBIT) 0.96 0.98 0.95 0.98 0.96 3.24 -3.43 1.73 -4.13 0.94 0.93 0.58 0.59 0.58 0.62 0.96 0.95 0.95 0.94 1.03 1.031
EBIT Margin 0.06 0.05 0.05 0.14 0.14 -0.00 0.00 -0.01 0.00 0.13 0.14 0.17 0.17 0.17 0.17 0.16 0.15 0.15 0.15 0.16 0.158
Asset Turnover 0.64 0.62 0.63 0.62 0.62 0.63 0.64 0.63 0.65 0.69 0.71 0.70 0.72 0.72 0.73 0.71 0.70 1.42 0.72 0.70 0.702
Equity Multiplier 1.31 1.32 1.32 1.34 1.31 1.35 1.37 1.40 1.36 1.38 1.41 1.43 1.40 1.40 1.42 1.43 1.43 1.42 1.41 1.43 1.427
Per Share
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
EPS (Diluted TTM) $19.81 $18.19 $12.97 $68.00 $66.84 $-23.92 $-21.09 $-39.67 $-29.97 $72.93 $78.12 $73.35 $74.52 $74.36 $79.75 $106.21 $92.61 $92.72 $94.94 $115.38 $115.38
Book Value/Share $778.37 $798.12 $802.44 $842.66 $864.71 $816.25 $778.49 $779.73 $804.66 $849.53 $841.65 $842.64 $850.86 $822.29 $823.88 $838.52 $826.86 $5.46 $876.37 $917.54 $931.31
Tangible Book/Share $495.29 $509.76 $489.77 $517.52 $525.14 $544.90 $518.21 $524.29 $545.07 $587.27 $583.96 $611.87 $619.98 $596.32 $592.95 $617.45 $610.26 $-222.62 $636.77 $696.15 $696.15
Revenue/Share $642.04 $647.87 $658.17 $664.80 $671.53 $701.32 $699.11 $740.10 $764.47 $818.38 $851.13 $831.38 $844.37 $860.95 $875.73 $878.84 $864.21 $859.79 $893.10 $900.12 $908.20
FCF/Share $34.25 $55.42 $56.86 $25.47 $21.58 $0.04 $19.01 $33.31 $42.77 $90.40 $161.61 $170.60 $205.08 $185.11 $132.40 $158.97 $125.65 $97.19 $92.00 $95.24 $109.22
OCF/Share $84.69 $118.55 $115.28 $114.96 $115.58 $98.14 $112.11 $98.53 $99.66 $128.73 $191.89 $200.02 $228.18 $208.36 $160.25 $178.48 $143.59 $113.51 $104.55 $110.70 $127.71
Cash/Share $137.64 $190.78 $170.49 $210.50 $175.01 $184.11 $161.22 $155.63 $125.93 $183.51 $231.12 $261.45 $248.98 $244.48 $225.82 $275.35 $248.64 $194.27 $190.33 $255.90 $243.53
EBITDA/Share $77.34 $75.81 $72.64 $134.47 $137.30 $45.27 $47.54 $37.49 $46.89 $158.60 $169.32 $192.71 $196.40 $197.04 $201.11 $196.95 $180.61 $181.95 $189.87 $198.73 $198.73
Debt/Share $25.09 $49.73 $52.98 $82.23 $56.14 $100.37 $95.96 $96.03 $92.76 $93.75 $94.73 $96.80 $0.00 $0.00 $0.00 $100.27 $0.72 $0.71 $111.78 $106.69 $106.69
Net Debt/Share $-112.55 $-141.05 $-117.50 $-128.28 $-118.87 $-83.75 $-65.25 $-59.60 $-33.17 $-89.76 $-136.39 $-164.65 $-248.98 $-244.48 $-225.82 $-175.08 $-247.92 $-193.56 $-78.54 $-149.20 $-149.20
Academic Models
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 6 5 4 4 5 5 6 5 6 8 7 8 7 7 8 8 5 7 6 7 7
Beneish M-Score -2.71 -2.96 -2.88 -2.54 -2.55 -3.00 -3.13 -3.11 -3.08 -2.67 -3.02 -3.03 -3.28 -3.26 -3.01 -3.03 -2.89 -105.58 -2.48 -2.47 -2.465
Ohlson O-Score snapshot only -11.590
ROIC (Greenblatt) snapshot only 21.00%
Net-Net WC snapshot only $314.33
EVA snapshot only $11015111921.96
Credit
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Credit Rating snapshot only AA-
Credit Score 77.75 80.25 80.25 82.75 82.75 52.05 56.35 54.15 59.65 81.50 81.50 81.50 78.30 77.70 78.95 82.75 82.75 82.75 82.75 82.75 82.750
Credit Grade snapshot only 4
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 100.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms